Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boston Sci In China: Investment Chases Big Growth

This article was originally published in The Gray Sheet

Executive Summary

While Boston Scientific’s core cardiology business units continue to face steep growth challenges in the U.S, China’s massive population remains essentially an untapped market.

You may also be interested in...

Boston Scientific Continues Worldwide Restructuring, Plans Job Cuts

The cuts expand on a 2011 restructuring plan, with hopes of reducing operating expenses by up to $375 million at the end of 2013.

St. Jude Restructuring Will Cut 300 Jobs, Save Up To $60 Million In 2013

Move will realign four product divisions into two new operating units to support growth opportunities, help offset impact of 2.3% device tax set to take effect next year.

News In Brief

Consensus document issued on transcatheter heart valves. Boston Scientific launches Asia-Pacific organization. More news briefs.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts